CN105963178B - Has effects that the cosmetic composition of red blood silk - Google Patents

Has effects that the cosmetic composition of red blood silk Download PDF

Info

Publication number
CN105963178B
CN105963178B CN201610316558.XA CN201610316558A CN105963178B CN 105963178 B CN105963178 B CN 105963178B CN 201610316558 A CN201610316558 A CN 201610316558A CN 105963178 B CN105963178 B CN 105963178B
Authority
CN
China
Prior art keywords
red blood
parts
blood silk
cosmetic composition
extract
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN201610316558.XA
Other languages
Chinese (zh)
Other versions
CN105963178A (en
Inventor
胡喜芬
黄云薇
其他发明人请求不公开姓名
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Guangzhou Jing Yan Biotechnology Co Ltd
Original Assignee
Guangzhou Jing Yan Biotechnology Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Guangzhou Jing Yan Biotechnology Co Ltd filed Critical Guangzhou Jing Yan Biotechnology Co Ltd
Priority to CN201610316558.XA priority Critical patent/CN105963178B/en
Publication of CN105963178A publication Critical patent/CN105963178A/en
Application granted granted Critical
Publication of CN105963178B publication Critical patent/CN105963178B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/164Amides, e.g. hydroxamic acids of a carboxylic acid with an aminoalcohol, e.g. ceramides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/25Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/48Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/481Astragalus (milkvetch)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/63Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
    • A61K36/634Forsythia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/73Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/896Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
    • A61K36/8964Anemarrhena
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06Tripeptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/39Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64Proteins; Peptides; Derivatives or degradation products thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/65Collagen; Gelatin; Keratin; Derivatives or degradation products thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/68Sphingolipids, e.g. ceramides, cerebrosides, gangliosides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/92Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
    • A61K8/922Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/59Mixtures
    • A61K2800/592Mixtures of compounds complementing their respective functions
    • A61K2800/5922At least two compounds being classified in the same subclass of A61K8/18

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • Birds (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Inorganic Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Cosmetics (AREA)

Abstract

Having effects that the cosmetic composition of red blood silk the invention discloses a kind of, the composition contains anemarrhena asphodefoides extract, hamamelis extract and Ruscus extract, the elasticity of capillary can effectively be enhanced, reduce the permeability of capillary, it diminishes inflammation, the capillary of shrinkage expansion restores normal microcirculation, plays and good goes red blood silk effect.

Description

Has effects that the cosmetic composition of red blood silk
Technical field
The invention belongs to cosmetic field, it is specifically related to a kind of having effects that the cosmetic composition of red blood silk.
Background technology
In recent years, the related dermals problems such as red blood trace on face, the colour of skin be uneven are increasingly becoming cosmetic industry and medicine row The hot spot of industry research.Red blood trace on face, medically also known as facial telangiectasias, that is, capillary wall elasticity drop Low, brittleness enhancing, the non-uniform expansion of continuous vessel even ruptures, and causes skin of face general red, the hair of the visible expansion of naked eyes Thin blood vessel, be often accompanied by red or aubergine plaque-like, it is dotted, linear or starlike phenomena such as, referred to as telangiectasia.Forming face The reason of portion's red blood silk, complexity was various, some familial inheritance diseases lead to the easypro contracting defect of congenital capillary, form heredity and go out The symptoms such as courageous and upright telangiectasis, spider shape telangiectasis, in addition plateau climate anoxic lead to capillary compensatory Expansion is also a kind of reason.However, hormonal dependent capillary caused by the abuse of current hormone, especially glucocorticoid It expands into as main cause, specifically, hormone product, which is used for a long time, leads to the collagenous degeneration of local skin, capillary elasticity drop It is low and become fragile, cause telangiectasis, atrophoderma and purpura of local skin etc..
The red blood silk that facial telangiectasias causes not only seriously affects patient's appearance, is also resulted in very to the psychology of patient Big burden.However that currently there are a variety of is not notable for removing red blood silk cosmetic industry, and not up to its advertisement The effect declared.
Part material according to the present invention is described as follows:
Rhizoma anemarrhenae, the rhizome of liliaceous plant rhizoma anemarrhenae, bitter is cold in nature, return lung, stomach, kidney channel, and there is clearing heat-fire, enriching yin to moisten Dry, relieving restlessness and other effects of quenching the thirst.Zhao Shujin etc. exists《Journal of Chinese Hospital Pharmacy》The paper that 02 phase in 2000 delivers《Timosaponin and Corrective action of its aglycon to animal model beta-2 adrenoceptor》Middle disclosure timosaponin can substantially reduced glucocorticoid draw The side effect risen.
Witch hazel, Hamamelidaceae Hamamelis plant, containing there are many tannin matter, releive, restrain, antibacterial and other effects.
Butcher's broom, Liliaceae butcher's broom platymiscium, chemical composition are mainly butcher's broom saponin(e.The confirmation of modern age pharmacological research, Butcher's broom saponin(e has enhancing angiokinesis effect and intravenous tension effect.
Ivy, Araliaceae Hedera perennial evergreen climbing shrub, complete stool can be used as medicine, and flat property and sweet taste has wind-dispelling Wet, activating blood circulation and reducing swelling effect.
Fructus Forsythiae, Oleaceae forsythia, bitter cool in nature play the role of clearing heat and detoxicating, mass dissipating and swelling eliminating.
Radix Astragali, Papilionaceae Astragalus, the sweet tepor of property, have enhancing body's immunity, liver protection, diuresis, anti-aging, Resisting stress, decompression and wide antibacterial action.
Invention content
Having effects that the cosmetic composition of red blood silk the purpose of the present invention is to provide a kind of.
The object of the invention is achieved through the following technical solutions:
A kind of have effects that the cosmetic composition of red blood silk, described to have effects that the cosmetic composition of red blood silk Each component containing following mass parts:0.1-5 parts of anemarrhena asphodefoides extract, 0.1-5 parts of hamamelis extract, Ruscus extract 0.1- 5 parts.
Some embodiments wherein, it is described to have effects that the cosmetic composition of red blood silk contains each of following mass parts Component:2.5 parts of anemarrhena asphodefoides extract, 2.5 parts of hamamelis extract, 2.5 parts of Ruscus extract.
Preferably, the cosmetic composition with red blood silk of the present invention can also contain following mass parts Component:0.1-3 parts of ivy extract, 0.1-3 parts of forsythia suspense extraction, 0.1-3 parts of Astragalus Root P.E.
Preferably, the cosmetic composition with red blood silk of the present invention can also contain following mass parts Component:0.1-5 parts of -1 copper solution of 0.1% tripeptides, 0.1-2 parts of collagen.
Preferably, the cosmetic composition with red blood silk of the present invention can also contain following mass parts Component:0.1-1 parts of Cer NP, 0.1-2 parts of prinsepia utilis royle oil.
The cosmetic composition with red blood silk of the present invention has the elasticity of enhancing capillary, reduces capillary The permeability of blood vessel, diminishes inflammation, and the capillary of shrinkage expansion restores the effect of normal microcirculation, is added to skin care item Common matrix or carrier, can be made into facial mask, Essence, skin care cream lotion, skin care gel.
The present invention also provides one kind removing red blood silk Essence, includes the component of following mass percent:
Double-PEG/PPG-20/5 dimethyl silicone polymers 0.2-0.5%
Methoxyl group PEG/PPG-25/4 dimethyl silicone polymers 0.2-0.5%
Caprylic/capric triglyceride 0.1-2%
Ring five dimethyl silicone polymer 1-5%
Isononyl isononanoate 0.5-2%
Pentaerythritol tetraoctyl stearate 0.5-2%
Glycerine 1-5%
Propylene glycol 1-5%
Carbomer 0.1-0.3%
Pentanediol 3-5%
Arginine 0.1-0.3%
The above-mentioned cosmetic composition 0.3-39% with red blood silk
Water surplus.
Compared with the existing technology, the present invention has the following advantages and beneficial effects:1, the present invention is according to Chinese medicine monarch The medication of the thought side of sending there is enhancing angiokinesis effect and intravenous tension effect specifically, Ruscus extract is monarch drug in a prescription; Hamamelis extract is ministerial drug, rises and releives, astriction;Anemarrhena asphodefoides extract is adjuvant, has clearing heat-fire effect, can be with Inhibit various side effects caused by glucocorticoid.Ruscus extract, anemarrhena asphodefoides extract and hamamelis extract share, and can have The elasticity of effect enhancing capillary, reduces the permeability of capillary, diminishes inflammation, and the capillary of shrinkage expansion restores just Normal microcirculation is played and good goes red blood silk effect.2, ivy extract, forsythia suspense extraction, Astragalus Root P.E share, can Play the role of removing free radical, mass dissipating and swelling eliminating, the adjuvant for improving immunity of organisms.3, -1 copper of tripeptides and collagen share, can be with Hyperplasia and collagen is promoted to generate, enhancing capillary elasticity, to going red blood silk effect to have enhancing effect.4, green bur Oil contains abundant unsaturated fatty acid needed by human, is shared with Cer NP, can thicken keratoderma, restore skin The natural cover for defense protects capillary under skin to provide good environment from environmental stimuli for the reparation of capillary.
Specific implementation mode
With reference to embodiment, the present invention is described in further detail, and embodiments of the present invention are not limited thereto, For not specifically specified technological parameter or condition, routine techniques progress can refer to.
Embodiment 1
One kind removing red blood silk Essence, includes the component of following mass percent:
Double-PEG/PPG-20/5 dimethyl silicone polymers 0.2%
Methoxyl group PEG/PPG-25/4 dimethyl silicone polymers 0.5%
Caprylic/capric triglyceride 0.1%
Ring five dimethyl silicone polymer 5%
Isononyl isononanoate 0.5%
Pentaerythritol tetraoctyl stearate 2%
Glycerine 1%
Propylene glycol 5%
Carbomer 0.1%
Pentanediol 5%
Arginine 0.1%
Anemarrhena asphodefoides extract 0.1%
Hamamelis extract 5%
Ruscus extract 0.1%
Water surplus.
Production technology:1, first double-PEG/PPG-20/5 dimethyl silicone polymers, methoxyl group PEG/PPG-25/4 are gathered Dimethyl siloxane, caprylic/capric triglyceride, ring five dimethyl silicone polymer, isononyl isononanoate, pentaerythrite four are different Stearate puts into oil phase pot, and mixing is heated to 80 DEG C, and oil phase is made in stirring and dissolving;2, again by water, glycerine, propylene glycol, card Wave nurse, pentanediol input emulsification pot, mixing are heated to 80 DEG C, and water phase is made in stirring and dissolving;3, oil phase is pumped into emulsification pot, Matter(Homogeneous rate is 3000rpm)Insulated and stirred after 3 minutes(Stir speed (S.S.) is 30rpm)45 minutes.4, water dissolution is used in advance Good arginine, adds emulsification pot, stirs evenly;5, room temperature is cooled to, anemarrhena asphodefoides extract, hamamelis extract and phyllodium is added Extract is set, is stirred evenly, you can.
Embodiment 2
One kind removing red blood silk Essence, includes the component of following mass percent:
Double-PEG/PPG-20/5 dimethyl silicone polymers 0.3%
Methoxyl group PEG/PPG-25/4 dimethyl silicone polymers 0.3%
Caprylic/capric triglyceride 1%
Ring five dimethyl silicone polymer 3%
Isononyl isononanoate 1%
Pentaerythritol tetraoctyl stearate 1%
Glycerine 3%
Propylene glycol 3%
Carbomer 0.2%
Pentanediol 4%
Arginine 0.2%
Anemarrhena asphodefoides extract 2.5%
Hamamelis extract 2.5%
Ruscus extract 2.5%
Water surplus.
Preparation process similar embodiment 1, details are not described herein.
Embodiment 3
One kind removing red blood silk Essence, includes the component of following mass percent:
Double-PEG/PPG-20/5 dimethyl silicone polymers 0.5%
Methoxyl group PEG/PPG-25/4 dimethyl silicone polymers 0.2%
Caprylic/capric triglyceride 2%
Ring five dimethyl silicone polymer 1%
Isononyl isononanoate 2%
Pentaerythritol tetraoctyl stearate 0.5%
Glycerine 5%
Propylene glycol 1%
Carbomer 0.3%
Pentanediol 3%
Arginine 0.3%
Anemarrhena asphodefoides extract 5%
Hamamelis extract 0.1%
Ruscus extract 5%
Water surplus.
Preparation process similar embodiment 1, details are not described herein.
Embodiment 4
One kind removing red blood silk Essence, includes the component of following mass percent:
Double-PEG/PPG-20/5 dimethyl silicone polymers 0.3%
Methoxyl group PEG/PPG-25/4 dimethyl silicone polymers 0.3%
Caprylic/capric triglyceride 1%
Ring five dimethyl silicone polymer 3%
Isononyl isononanoate 1%
Pentaerythritol tetraoctyl stearate 1%
Glycerine 3%
Propylene glycol 3%
Carbomer 0.2%
Pentanediol 4%
Arginine 0.2%
Anemarrhena asphodefoides extract 2.5%
Hamamelis extract 2.5%
Ruscus extract 2.5%
Ivy extract 0.1%
Forsythia suspense extraction 3%
Astragalus Root P.E 0.1%
Water surplus.
Preparation process similar embodiment 1, details are not described herein.
Embodiment 5
One kind removing red blood silk Essence, includes the component of following mass percent:
Double-PEG/PPG-20/5 dimethyl silicone polymers 0.3%
Methoxyl group PEG/PPG-25/4 dimethyl silicone polymers 0.3%
Caprylic/capric triglyceride 1%
Ring five dimethyl silicone polymer 3%
Isononyl isononanoate 1%
Pentaerythritol tetraoctyl stearate 1%
Glycerine 3%
Propylene glycol 3%
Carbomer 0.2%
Pentanediol 4%
Arginine 0.2%
Anemarrhena asphodefoides extract 2.5%
Hamamelis extract 2.5%
Ruscus extract 2.5%
Ivy extract 3%
Forsythia suspense extraction 0.1%
Astragalus Root P.E 3%
Water surplus.
Preparation process similar embodiment 1, details are not described herein.
Embodiment 6
One kind removing red blood silk Essence, includes the component of following mass percent:
Double-PEG/PPG-20/5 dimethyl silicone polymers 0.3%
Methoxyl group PEG/PPG-25/4 dimethyl silicone polymers 0.3%
Caprylic/capric triglyceride 1%
Ring five dimethyl silicone polymer 3%
Isononyl isononanoate 1%
Pentaerythritol tetraoctyl stearate 1%
Glycerine 3%
Propylene glycol 3%
Carbomer 0.2%
Pentanediol 4%
Arginine 0.2%
Anemarrhena asphodefoides extract 2.5%
Hamamelis extract 2.5%
Ruscus extract 2.5%
Ivy extract 1%
Forsythia suspense extraction 1%
Astragalus Root P.E 1%
- 1 copper solution 0.1% of 0.1% tripeptides
Collagen 2%
Water surplus.
Preparation process similar embodiment 1, details are not described herein.
Embodiment 7
One kind removing red blood silk Essence, includes the component of following mass percent:
Double-PEG/PPG-20/5 dimethyl silicone polymers 0.3%
Methoxyl group PEG/PPG-25/4 dimethyl silicone polymers 0.3%
Caprylic/capric triglyceride 1%
Ring five dimethyl silicone polymer 3%
Isononyl isononanoate 1%
Pentaerythritol tetraoctyl stearate 1%
Glycerine 3%
Propylene glycol 3%
Carbomer 0.2%
Pentanediol 4%
Arginine 0.2%
Anemarrhena asphodefoides extract 2.5%
Hamamelis extract 2.5%
Ruscus extract 2.5%
Ivy extract 1%
Forsythia suspense extraction 1%
Astragalus Root P.E 1%
- 1 copper solution 5% of 0.1% tripeptides
Collagen 0.1%
Water surplus.
Preparation process similar embodiment 1, details are not described herein.
Embodiment 8
One kind removing red blood silk Essence, includes the component of following mass percent:
Double-PEG/PPG-20/5 dimethyl silicone polymers 0.3%
Methoxyl group PEG/PPG-25/4 dimethyl silicone polymers 0.3%
Caprylic/capric triglyceride 1%
Ring five dimethyl silicone polymer 3%
Isononyl isononanoate 1%
Pentaerythritol tetraoctyl stearate 1%
Glycerine 3%
Propylene glycol 3%
Carbomer 0.2%
Pentanediol 4%
Arginine 0.2%
Anemarrhena asphodefoides extract 2.5%
Hamamelis extract 2.5%
Ruscus extract 2.5%
Ivy extract 1%
Forsythia suspense extraction 1%
Astragalus Root P.E 1%
- 1 copper solution 2% of 0.1% tripeptides
Collagen 1%
Cer NP 0.1%
Prinsepia utilis royle oil 2%
Water surplus.
Preparation process similar embodiment 1, details are not described herein.
Embodiment 9
One kind removing red blood silk Essence, includes the component of following mass percent:
Double-PEG/PPG-20/5 dimethyl silicone polymers 0.3%
Methoxyl group PEG/PPG-25/4 dimethyl silicone polymers 0.3%
Caprylic/capric triglyceride 1%
Ring five dimethyl silicone polymer 3%
Isononyl isononanoate 1%
Pentaerythritol tetraoctyl stearate 1%
Glycerine 3%
Propylene glycol 3%
Carbomer 0.2%
Pentanediol 4%
Arginine 0.2%
Anemarrhena asphodefoides extract 2.5%
Hamamelis extract 2.5%
Ruscus extract 2.5%
Ivy extract 1%
Forsythia suspense extraction 1%
Astragalus Root P.E 1%
- 1 copper solution 2% of 0.1% tripeptides
Collagen 1%
Cer NP 1%
Prinsepia utilis royle oil 0.1%
Water surplus.
Preparation process similar embodiment 1, details are not described herein.
Embodiment 10
To going red blood silk Essence to carry out efficacy assessments prepared by embodiment 1-9, and comparative example 1-4 is set, wherein right Ratio 4 removes red blood silk Essence to be commercially available, and specific test is as follows:
Comparative example 1
One kind removing red blood silk Essence, includes the component of following mass percent:
Double-PEG/PPG-20/5 dimethyl silicone polymers 0.3%
Methoxyl group PEG/PPG-25/4 dimethyl silicone polymers 0.3%
Caprylic/capric triglyceride 1%
Ring five dimethyl silicone polymer 3%
Isononyl isononanoate 1%
Pentaerythritol tetraoctyl stearate 1%
Glycerine 3%
Propylene glycol 3%
Carbomer 0.2%
Pentanediol 4%
Arginine 0.2%
Anemarrhena asphodefoides extract 4%
Hamamelis extract 4%
Water surplus.
Preparation process similar embodiment 1, details are not described herein.
Comparative example 2
One kind removing red blood silk Essence, includes the component of following mass percent:
Double-PEG/PPG-20/5 dimethyl silicone polymers 0.3%
Methoxyl group PEG/PPG-25/4 dimethyl silicone polymers 0.3%
Caprylic/capric triglyceride 1%
Ring five dimethyl silicone polymer 3%
Isononyl isononanoate 1%
Pentaerythritol tetraoctyl stearate 1%
Glycerine 3%
Propylene glycol 3%
Carbomer 0.2%
Pentanediol 4%
Arginine 0.2%
Hamamelis extract 4%
Ruscus extract 4%
Water surplus.
Preparation process similar embodiment 1, details are not described herein.
Comparative example 3
One kind removing red blood silk Essence, includes the component of following mass percent:
Double-PEG/PPG-20/5 dimethyl silicone polymers 0.3%
Methoxyl group PEG/PPG-25/4 dimethyl silicone polymers 0.3%
Caprylic/capric triglyceride 1%
Ring five dimethyl silicone polymer 3%
Isononyl isononanoate 1%
Pentaerythritol tetraoctyl stearate 1%
Glycerine 3%
Propylene glycol 3%
Carbomer 0.2%
Pentanediol 4%
Arginine 0.2%
Anemarrhena asphodefoides extract 4%
Ruscus extract 4%
Water surplus.
Preparation process similar embodiment 1, details are not described herein.
Go red blood silk efficacy test method as follows:Each experimental group chooses 15 volunteers, and age 25-55 Sui, face has Red blood silk, can be by Normalization rule product, and cooperating personnel complete appraisal as required, has certain expressive faculty, Impression after energy actual response use;Application method:It is continuous 12 weeks on probation, once in the morning and once at night, and photo archive;It compares the 0th day With the 12nd week photo, 30% or more red blood silk removal was effective, and it is effective that red blood silk, which removes 5%-30%,;Red blood silk removal 5% with It is lower or it is unconspicuous be invalid.Specific test result such as table 1.
Table 1 removes red blood silk efficacy test record sheet
It is effective Effectively In vain
Embodiment 1 3 5 7
Embodiment 2 5 8 2
Embodiment 3 4 6 5
Embodiment 4 8 3 4
Embodiment 5 7 5 3
Embodiment 6 9 4 2
Embodiment 7 10 2 3
Embodiment 8 11 3 1
Embodiment 9 12 3 0
Comparative example 1 0 7 8
Comparative example 2 0 6 9
Comparative example 3 0 8 7
Comparative example 4 1 4 10
From upper table 1:Obtained by embodiment 1-9 go to red blood silk Essence and 4 commercial product of comparative example to compare it is found that The present invention's goes red blood silk cosmetic composition effect apparent;Embodiment 1-3 is with comparative example 1-3 comparisons it is found that butcher's broom extracts Object, anemarrhena asphodefoides extract and hamamelis extract are shared goes red blood silk effect with concertedness;Embodiment 4-5 and embodiment 1-3 Comparison is it is found that ivy extract, forsythia suspense extraction, Astragalus Root P.E share, to going red blood silk effect to have enhancing effect;Implement Example 6-7 and embodiment 4-5 is compared it is found that -1 copper of tripeptides and collagen share, and can further enhance red blood silk effect;Embodiment 8- 9 comparisons go red blood silk effect to have facilitation composition it is found that prinsepia utilis royle oil is shared with Cer NP.
The above embodiment is a preferred embodiment of the present invention, but embodiments of the present invention are not by above-described embodiment Limitation, it is other it is any without departing from the spirit and principles of the present invention made by changes, modifications, substitutions, combinations, simplifications, Equivalent substitute mode is should be, is included within the scope of the present invention.

Claims (8)

1. a kind of having effects that the cosmetic composition of red blood silk, which is characterized in that each component containing following mass parts:Know Female extract 0.1-5 parts, 0.1-5 parts of hamamelis extract, 0.1-5 parts of Ruscus extract.
2. according to claim 1 have effects that the cosmetic composition of red blood silk, which is characterized in that contain following matter Measure each component of part:2.5 parts of anemarrhena asphodefoides extract, 2.5 parts of hamamelis extract, 2.5 parts of Ruscus extract.
3. according to claim 1 have effects that the cosmetic composition of red blood silk, which is characterized in that described has The cosmetic composition of red blood silk effect is gone also to contain the component of following mass parts:0.1-3 parts of ivy extract, Fructus Forsythiae extraction 0.1-3 parts of object, 0.1-3 parts of Astragalus Root P.E.
4. according to claim 1 or 3 have effects that the cosmetic composition of red blood silk, which is characterized in that described Have effects that the cosmetic composition of red blood silk also contains the component of following mass parts:- 1 copper solution 0.1-5 of 0.1% tripeptides Part, 0.1-2 parts of collagen.
5. according to claim 1 or 3 have effects that the cosmetic composition of red blood silk, which is characterized in that described Have effects that the cosmetic composition of red blood silk also contains the component of following mass parts:0.1-1 parts of Cer NP, green bur It is 0.1-2 parts oily.
6. claim 1-5 any one of them has effects that application of the cosmetic composition of red blood silk in cosmetics.
7. the application according to claim 6 for having effects that the cosmetic composition of red blood silk in cosmetics, special Sign is have containing claim 1-5 any one of them that mass fraction is 0.3-39% in the cosmetics and go red blood silk The cosmetic composition of effect.
8. one kind removing red blood silk Essence, which is characterized in that include the component of following mass percent:
Double-PEG/PPG-20/5 dimethyl silicone polymers 0.2-0.5%
Methoxyl group PEG/PPG-25/4 dimethyl silicone polymers 0.2-0.5%
Caprylic/capric triglyceride 0.1-2%
Ring five dimethyl silicone polymer 1-5%
Isononyl isononanoate 0.5-2%
Pentaerythritol tetraoctyl stearate 0.5-2%
Glycerine 1-5%
Propylene glycol 1-5%
Carbomer 0.1-0.3%
Pentanediol 3-5%
Arginine 0.1-0.3%
Claim 1-5 any one of them has effects that the cosmetic composition 0.3-39% of red blood silk
Water surplus.
CN201610316558.XA 2016-05-15 2016-05-15 Has effects that the cosmetic composition of red blood silk Expired - Fee Related CN105963178B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201610316558.XA CN105963178B (en) 2016-05-15 2016-05-15 Has effects that the cosmetic composition of red blood silk

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201610316558.XA CN105963178B (en) 2016-05-15 2016-05-15 Has effects that the cosmetic composition of red blood silk

Publications (2)

Publication Number Publication Date
CN105963178A CN105963178A (en) 2016-09-28
CN105963178B true CN105963178B (en) 2018-08-31

Family

ID=56992585

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201610316558.XA Expired - Fee Related CN105963178B (en) 2016-05-15 2016-05-15 Has effects that the cosmetic composition of red blood silk

Country Status (1)

Country Link
CN (1) CN105963178B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106362053A (en) * 2016-11-03 2017-02-01 惠州市蕙薏美生物科技有限公司 Externally-applied traditional Chinese medicine composition with function of removing couperose skin and skin-care preparation of composition
CN108743476A (en) * 2018-07-01 2018-11-06 佛山市芊茹化妆品有限公司 A kind of composite plant fermentation composition with red blood silk and preparation method
CN109316432B (en) * 2018-11-22 2021-09-07 蓓悠清(广东)健康科技有限公司 Air cushion BB cream and preparation method thereof
CN111437222A (en) * 2020-02-26 2020-07-24 广东省粤企产业创新研究院 Toner composition, preparation method thereof and toner

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103585085A (en) * 2013-11-15 2014-02-19 郑浩 Redness relieving mask
CN104547064A (en) * 2013-10-18 2015-04-29 王恩瀚 Pharmaceutical composition for treating facial telangiectasis and preparation method and use thereof
CN105168103A (en) * 2015-10-29 2015-12-23 青岛海之源智能技术有限公司 Deep sea caviar essence capable of refining pores and preparation method thereof

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104547064A (en) * 2013-10-18 2015-04-29 王恩瀚 Pharmaceutical composition for treating facial telangiectasis and preparation method and use thereof
CN103585085A (en) * 2013-11-15 2014-02-19 郑浩 Redness relieving mask
CN105168103A (en) * 2015-10-29 2015-12-23 青岛海之源智能技术有限公司 Deep sea caviar essence capable of refining pores and preparation method thereof

Also Published As

Publication number Publication date
CN105963178A (en) 2016-09-28

Similar Documents

Publication Publication Date Title
CN105963178B (en) Has effects that the cosmetic composition of red blood silk
CN103169631B (en) A kind of submissive glossy shampoo and preparation method containing Chinese medicine composition
US10471000B2 (en) Method for manufacturing anti-wrinkle funtional cosmetics
CN102113987B (en) Cosmetic containing natural plant extractives and preparation method thereof
CN109602668A (en) A kind of anti-aging anti-wrinkle composition and its application
CN106420459B (en) A kind of ginseng water Essence living and preparation method thereof and the facial mask comprising it
CN106511221A (en) Acne-removing facial cleanser
CN105342874A (en) Composition with skin tightening and anti-aging functions and preparation of composition with skin tightening and anti-aging functions
CN101869541B (en) Skin care product comprising plant extract and preparation method thereof
CN109330965A (en) A kind of cosmetic composition containing plant extracts
CN109330976A (en) A kind of anti-acne plant composition and preparation method thereof
US20100092582A1 (en) Topical Hair Care Formulation and Method of Making
CN106333909B (en) A kind of desalination red blood trace on face repairs the lotion and preparation method thereof of skin
JP2003113030A (en) Skin care preparation
CN108066209A (en) A kind of whitening and spot eliminating cream and preparation method thereof
CN108904415A (en) A kind of anti-acne essence of micropin containing sponge and cell factor
CN108096174A (en) A kind of compound plant extract with hair care anti-off effect and preparation method and application
CN107137336A (en) A kind of anti acne of traditional Chinese medicine facial mask and preparation method thereof
CN106726993A (en) Chinese medicine hair cream and preparation method
CN106177925A (en) A kind of Lac regis apis cosmetic health product
CN105640836B (en) A kind of surfactant and preparation method thereof containing lotus active constituent
US8586105B2 (en) Topical hair care formulation and method of making
CN108210433A (en) Cardamom skin care compositions and its application with oil-control and/or acne-removing
CN107028843A (en) A kind of efficient acne eliminating cream and preparation method thereof
CN110090193B (en) Acne-removing moisturizing essence with fat-reducing effect and preparation method thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
TA01 Transfer of patent application right

Effective date of registration: 20180727

Address after: 510000 Building 4-5, Building A, Jingjin Industrial Zone, West Avenue, Xiamao 20, Baiyun Lake Street, Baiyun District, Guangzhou City, Guangdong Province

Applicant after: Guangzhou Jing Yan Biotechnology Co., Ltd.

Address before: 528000 2AP68 two, No. 82 Jinhua Road, Chancheng District, Foshan, Guangdong.

Applicant before: FOSHAN QIANRU COSMETICS CO., LTD.

TA01 Transfer of patent application right
GR01 Patent grant
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20180831

Termination date: 20210515

CF01 Termination of patent right due to non-payment of annual fee